Tirecat
Spin-off from a nanoscience research institute developing bioinspired, micron‑thin adhesive polymer membranes for regenerative medicine. The organization focuses on materials that adhere to wet tissue, are biocompatible, antimicrobial, degradable in vivo, and can be tuned to deliver cells or small molecules. The company reports preclinical safety and efficacy data and is preparing a first membrane candidate for clinical evaluation while collaborating with research centers, hospitals, and investors.
Industries
Nr. of Employees
small (1-50)
Tirecat
RAMBLA CATALUNYA, 78 – 3rd Floor, Door 1B, 08008 Barcelona, Spain (ICN2 / UAB Campus, 08193 Bellaterra, Barcelona)
Products
Tissue-adhesive bioinspired membrane (clinical-stage candidate)
Micron‑thin adhesive polymer membrane designed to adhere to wet tissue, support cell growth, provide antimicrobial protection, and degrade in vivo to promote tissue regeneration.
Tissue-adhesive bioinspired membrane (clinical-stage candidate)
Micron‑thin adhesive polymer membrane designed to adhere to wet tissue, support cell growth, provide antimicrobial protection, and degrade in vivo to promote tissue regeneration.
Expertise Areas
- Biomaterials for tissue regeneration
- Adhesive medical membranes
- Antimicrobial material design
- Preclinical validation and safety assessment
Key Technologies
- Bioinspired polymer membranes
- Adhesive biomaterials for wet tissues
- Biocompatible scaffold materials
- Antimicrobial material technologies
News & Updates
Announcement of €170,000 investment from Grow Venture Partners to support development of a bioinspired adhesive membrane; reports preclinical data indicating up to 40% faster tissue regeneration.
Selected as best deep‑tech start‑up in the 5th Open Call for Deep Tech Startups at the Transfiere congress; recognition includes monetary award and exhibition space.
Background on technology origin at a nanoscience institute and description of membrane features (adhesion, biocompatibility, antimicrobial, degradability) and intent to enter clinical phases.
Awarded best deep‑tech start‑up in the 5th Open Call for Deep Tech Startups at Transfiere 2025.
Raised €170,000 from Grow Venture Partners to advance development and team growth.
Announcement of €170,000 investment from Grow Venture Partners to support development of a bioinspired adhesive membrane; reports preclinical data indicating up to 40% faster tissue regeneration.
Selected as best deep‑tech start‑up in the 5th Open Call for Deep Tech Startups at the Transfiere congress; recognition includes monetary award and exhibition space.
Background on technology origin at a nanoscience institute and description of membrane features (adhesion, biocompatibility, antimicrobial, degradability) and intent to enter clinical phases.
Awarded best deep‑tech start‑up in the 5th Open Call for Deep Tech Startups at Transfiere 2025.
Raised €170,000 from Grow Venture Partners to advance development and team growth.